# Synchronicity Pharma, Inc.: Form D filings

Synchronicity Pharma, Inc., a pharmaceuticals company in San Jose, CA, filed 9 Form D notices with the SEC between 2013 and 2022. The latest, on January 25, 2022, reports $1.6 million sold of a $3 million offering to 3 investors.

Find out what Synchronicity Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Synchronicity%20Pharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Synchronicity%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsynchronicity-pharma-inc-1593318)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Synchronicity%20Pharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Synchronicity%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsynchronicity-pharma-inc-1593318)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1416 Saratoga Avenue, #133, San Jose, CA, 95129
- Phone: (650) 235-4140
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1593318

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 25, 2022 | New notice | $3,000,000 | $1,600,000 | $1,400,000 | 3 | Jan 11, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331822000001/0001593318-22-000001-index.htm) |
| Oct 24, 2019 | New notice | $5,953,344 | $5,953,344 | $0 | 3 | Sep 18, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331819000002/0001593318-19-000002-index.htm) |
| Jun 20, 2018 | New notice | $1,500,000 | $1,500,000 | $0 | 3 | Jun 13, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331818000002/0001593318-18-000002-index.htm) |
| Feb 19, 2016 | New notice | $47,206,800 | $29,727,145 | $17,479,655 | 2 | Feb 18, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331816000005/0001593318-16-000005-index.htm) |
| Oct 7, 2015 | Amendment | $12,000,000 | $9,100,000 | $2,900,000 | 2 | Jun 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331815000003/0001593318-15-000003-index.htm) |
| Jun 1, 2015 | Amendment | $10,000,000 | $7,800,000 | $2,200,000 | 2 | Jun 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331815000002/0001593318-15-000002-index.htm) |
| Jan 8, 2015 | Amendment | $6,500,000 | $5,000,000 | $1,500,000 | 2 | Jun 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331815000001/0001593318-15-000001-index.htm) |
| Jul 25, 2014 | New notice | $3,000,000 | $306,831 | $2,693,169 | 2 | Jun 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331814000001/0001593318-14-000001-index.htm) |
| Dec 3, 2013 | New notice | $15,989,400 | $14,796,231 | $1,193,169 | 2 | Nov 22, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1593318/000159331813000001/0001593318-13-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Blair B Jackson | Director |  |
| Steve B Kay | Director |  |
| Frederick B Craves | Director |  |
| Shu B Kurosaki | Executive Officer |  |
| Glenn B Batchelder | Executive Officer, Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Jan 24, 2022](https://specstream.ai/data/form-d/week/2022-01-24) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Synchronicity Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).